Effect of Tranexamic Acid Administration on Postoperative Ecchymosis and Edema in Excision of Lipomas

Dermatol Surg. 2021 Mar 1;47(3):345-348. doi: 10.1097/DSS.0000000000002680.

Abstract

Background: Previous studies have shown that systemic tranexamic acid reduces bleeding during soft tissue surgeries and reduces postoperative ecchymosis and edema experienced by surgical patients.

Objective: To evaluate the effect of postoperative tranexamic acid administration on the reduction of ecchymosis and edema after lipoma surgery.

Materials and methods: A total of 40 patients who underwent lipoma excision were included in the comparative analysis. In the tranexamic acid group (n = 20), 1 g of tranexamic acid was administered daily for 5 consecutive postoperative days. Tranexamic acid was not administered to the control group (n = 20). The severity of ecchymosis and edema at the first visit after surgery was rated on a 4-point scale by 2 blinded dermatologists.

Results: The mean interval of the initial visit after surgery was 1.1 ± 0.5 (range: 1-4) days. Mean ecchymosis scores were significantly lower in the tranexamic acid group (0.5 ± 0.8) than in the control group (1.2 ± 1.0) (p < .05). No statistical difference was seen in mean edema scores between groups (0.5 ± 0.6 in tranexamic acid vs 0.7 ± 0.8 in control).

Conclusion: We observed that postoperative administration of tranexamic acid significantly decreased ecchymosis in lipoma excision.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifibrinolytic Agents / therapeutic use*
  • Dermatologic Surgical Procedures / adverse effects*
  • Ecchymosis / prevention & control*
  • Edema / prevention & control*
  • Female
  • Humans
  • Lipoma / surgery*
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control
  • Retrospective Studies
  • Soft Tissue Neoplasms / surgery*
  • Subcutaneous Tissue / surgery
  • Tranexamic Acid / therapeutic use*

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid